Expertise in
6
conditions

Paul D. Nathan

Mount Vernon Hospital
Northwood, ENG, GB 
Expertise in
6
conditions
Mount Vernon Hospital
Northwood, ENG, GB 

Overview

Paul Nathan practices practicing medicine in Northwood, United Kingdom.

Mr. Nathan is highly rated in 6 conditions, according to our data. His clinical expertise encompasses Metastatic Uveal Melanoma, Melanoma, Uveal Melanoma, Renal Cell Carcinoma (RCC), and Nephrectomy.

He is actively involved in clinical research, co-authoring 56 peer reviewed articles and participating in 2 clinical trials.

Gender

Male

Locations

Mount Vernon Hospital
Northwood, ENG, United Kingdom

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Phase II Randomized, Open-label, Multi-center Study of the Safety and Efficacy of IMCgp100 Compared With Investigator Choice in HLA-A*0201 Positive Patients With Previously Untreated Advanced Uveal Melanoma
A Phase II Randomized, Open-label, Multi-center Study of the Safety and Efficacy of IMCgp100 Compared With Investigator Choice in HLA-A*0201 Positive Patients With Previously Untreated Advanced Uveal Melanoma
Enrollment Status: Completed
Publish Date: March 17, 2026
Intervention Type: Biological, Drug
Study Drugs: IMCgp100, Dacarbazine, Ipilimumab, Pembrolizumab
Study Phase: Phase 2
A Phase I/II Open-label, Multi-center Study of the Safety and Efficacy of IMCgp100 Using the Intra-patient Escalation Dosing Regimen in Patients With Advanced Uveal Melanoma
A Phase I/II Open-label, Multi-center Study of the Safety and Efficacy of IMCgp100 Using the Intra-patient Escalation Dosing Regimen in Patients With Advanced Uveal Melanoma
Enrollment Status: Completed
Publish Date: March 21, 2023
Intervention Type: Drug
Study Drug: IMCgp100
Study Phase: Phase 1/Phase 2
View 1 Less Clinical Trial

56 Total Publications

Five-year survival with tebentafusp in metastatic uveal melanoma.
Five-year survival with tebentafusp in metastatic uveal melanoma.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: March 02, 2026

Frequently Asked Questions about Paul D. Nathan

Is Paul D. Nathan a top-rated expert for Metastatic Uveal Melanoma?

MediFind is an objective health platform that identifies experts based on real-world data. Paul D. Nathan is classified as an Elite expert for Metastatic Uveal Melanoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Paul D. Nathan participate in research or clinical trials?

Yes. Paul D. Nathan has published 56 articles and abstracts on conditions like Metastatic Uveal Melanoma. You can view a list of Paul D. Nathan's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Nathan's expertise for a condition
ConditionClose
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile